Hersi Ahmad S, Alhabib Khalid F, AlFaleh Hussam F, AlNemer Khalid, AlSaif Shukri, Taraben Amir, Kashour Tarek, Abuosa Ahmed M, Al-Murayeh Mushabab A
Department of Cardiac Sciences, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ann Saudi Med. 2012 Jul-Aug;32(4):372-7. doi: 10.5144/0256-4947.2012.372.
Mortality in acute coronary syndrome (ACS) patients with ventricular arrhythmia (VA) has been shown to be higher than those without VA. However, there is a paucity of data on VA among ACS patients in the Middle Eastern countries.
Prospective study of patients admitted in 17 government hospitals with ACS between December 2005 and December 2007.
Patients were categorized as having VA if they experienced either ventricular fibrillation (VF) or sustained ventricular tachycardia (VT) or both.
Of 5055 patients with ACS enrolled in the SPACE registry, 168 (3.3%) were diagnosed with VA and 151 (98.8%) occurred in-hospital. The vast majority (74.4%) occurred in patients with ST-segment elevation myocardial infarction. In addition, males were twice as likely to develop VA than females (OR 1.7; 95% CI 1.13). Killip class >I (OR 2.0; 95% CI 1.3-3.1); and systolic blood pressure <90 mm Hg (OR 6.4; 95% CI 3.5-11.8) were positively associated with VA. Those admitted with hyperlipidemia (OR 0.49; 95% CI 0.3-0.7) had a lower risk of developing VA. Adverse in-hospital outcomes including re-myocardial infarction, cardiogenic shock, congestive heart failure, major bleeding, and stroke were higher for patients with VA (P≤.01 for all variables) and signified a poor prognosis. The in-hospital mortality rate was significantly higher in VA patients compared with non-VA patients (27% vs 2.2%; P=.001).
In-hospital VA in Saudi patients with ACS was associated with remarkably high rates of adverse events and increased in-hospital mortality. Using a well-developed registry data with a large number of patients, our study documented for the first time the prevalence and risk factors of VA in unselected population of ACS.
急性冠脉综合征(ACS)合并室性心律失常(VA)患者的死亡率高于无VA的患者。然而,中东国家ACS患者中VA的数据较少。
对2005年12月至2007年12月期间在17家政府医院收治的ACS患者进行前瞻性研究。
若患者经历心室颤动(VF)或持续性室性心动过速(VT)或两者皆有,则归类为患有VA。
在纳入SPACE注册研究的5055例ACS患者中,168例(3.3%)被诊断为VA,其中151例(98.8%)发生在住院期间。绝大多数(74.4%)发生在ST段抬高型心肌梗死患者中。此外,男性发生VA的可能性是女性的两倍(比值比1.7;95%置信区间1.13)。Killip分级>I(比值比2.0;95%置信区间1.3 - 3.1);收缩压<90 mmHg(比值比6.4;95%置信区间3.5 - 11.8)与VA呈正相关。患有高脂血症入院的患者发生VA的风险较低(比值比0.49;95%置信区间0.3 - 0.7)。VA患者的不良住院结局包括再发心肌梗死、心源性休克、充血性心力衰竭、大出血和中风的发生率更高(所有变量P≤0.01),预示预后不良。VA患者的住院死亡率显著高于非VA患者(27%对2.2%;P = 0.001)。
沙特ACS患者的住院VA与极高的不良事件发生率和住院死亡率增加相关。通过使用完善的注册研究数据和大量患者,我们的研究首次记录了未选择的ACS人群中VA的患病率和危险因素。